Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
scPharmaceuticals, Inc. (SCPH) had Debt to Equity Ratio of -9.96 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$11.75M |
|
$-19.74M |
|
$3.47M |
|
$8.28M |
|
$29.51M |
|
$-17.76M |
|
$-1.99M |
|
$-19.74M |
|
$-19.74M |
|
$-19.74M |
|
$-19.74M |
|
$-19.74M |
|
$-19.74M |
|
$-17.76M |
|
$-17.69M |
|
53.68M |
|
53.68M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$89.35M |
|
$0.05M |
|
$1.61M |
|
$90.96M |
|
$16.31M |
|
$51.05M |
|
$79.78M |
|
$96.09M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
50.28M |
|
| Cash Flow Statement Financials | |
$-17.14M |
|
-- |
|
$-0.97M |
|
$75.66M |
|
$57.54M |
|
$-18.11M |
|
$1.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.48 |
|
-- |
|
-- |
|
1.11 |
|
|
Debt to Equity Ratio |
-9.96 |
70.46% |
|
-151.10% |
|
-151.10% |
|
-- |
|
-167.99% |
|
-167.99% |
|
$-17.14M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.25 |
|
0.85 |
|
106.10 |
|
385.06% |
|
385.06% |
|
-21.70% |
|
-42.99% |
|
$-0.10 |
|
$-0.32 |
|
$-0.32 |
|